```html

Ureaplasma Infection – A Complete Patient‑Friendly Guide

Overview

Ureaplasma infection is an infection caused by two closely related species of bacteria: Ureaplasma urealyticum and Ureaplasma parvum. These microorganisms belong to the family Mycoplasmataceae and are the smallest free‑living bacteria capable of replicating without a cell wall.

Ureaplasma species are part of the normal genital flora for many adults, but when they multiply excessively or spread to sites where they do not belong, they can cause symptoms and complications.

Who is affected?

• Sexually active men and women – most cases are linked to sexual transmission.
• Pregnant women – colonization rates are slightly higher; the organisms can be passed to the baby during delivery.
• People with weakened immune systems, such as those with HIV or on immunosuppressive therapy.

Prevalence

Ureaplasma is one of the most common genital microorganisms detected in routine screening:

• Approximately 40‑70 % of sexually active adults carry Ureaplasma without any symptoms (CDC, 2022).
• In pregnant women, colonization rates range from 30‑50 % (World Health Organization, 2021).
• Symptomatic infection is far less common, affecting roughly 2‑5 % of those colonized.

Symptoms

Many people with Ureaplasma never develop symptoms. When symptoms do appear, they vary by sex, age, and site of infection.

In Women

• Urethritis: Burning or painful urination, increased urgency.
• Vaginal discharge: Watery or mucoid, sometimes with a mild odor.
• Pain during intercourse (dyspareunia): Discomfort that can affect relationship satisfaction.
• Pelvic pain: Localized lower‑abdominal discomfort, often mistaken for a urinary tract infection (UTI) or ovarian cyst.
• Pregnancy‑related issues: Preterm labor, chorioamnionitis, or low birth weight infants (CDC, 2022).

In Men

• Urethritis: Burning sensation during or after urination, white or cloudy urethral discharge.
• Epididymitis: Painful swelling of the testicle or epididymis, sometimes with fever.
• Prostatitis: Dull pelvic ache, difficulty urinating, painful ejaculation.
• Infertility: Reduced sperm motility and quality reported in some studies.

Other Possible Manifestations

• Conjunctivitis (eye infection) – rare, usually after direct contact with genital secretions.
• Joint pain or arthritis – especially in individuals with underlying autoimmune disease.
• Respiratory symptoms in newborns who acquire the organism during birth.

Causes and Risk Factors

How does infection occur?

Ureaplasma is transmitted mainly through sexual contact, including vaginal, oral, and anal intercourse. It can also be passed from mother to infant during delivery, or, less commonly, through contaminated fomites (e.g., towels) although this route is not well supported by evidence.

Key risk factors

• Multiple sexual partners or a new partner without prior testing.
• Inconsistent condom use – condoms reduce, but do not eliminate, risk because Ureaplasma can be present on skin surfaces.
• History of other sexually transmitted infections (STIs) – co‑infection with chlamydia, gonorrhea, or Mycoplasma genitalium is common.
• Pregnancy – hormonal changes and increased vascularity of the genital tract may promote colonization.
• Immunosuppression – HIV infection, organ transplantation, or long‑term corticosteroid therapy.
• Urethral instrumentation – catheterization, cystoscopy, or prostate biopsy can introduce the organism.

Diagnosis

Because Ureaplasma can be part of the normal flora, diagnosis requires a combination of symptom assessment and laboratory testing.

Specimen collection

• Women: First‑void urine, vaginal swab, or cervical swab.
• Men: First‑void urine or urethral swab; for epididymitis, a scrotal aspirate may be taken.

Laboratory tests

1. Nucleic Acid Amplification Tests (NAATs) – PCR‑based assays are the gold standard, offering >95 % sensitivity and specificity (CDC, 2022).
2. Culture – Can be performed on specialized media (Urea broth) but is slower (48–72 h) and less sensitive.
3. Serology – Antibody testing is not routinely used because antibodies do not correlate well with active infection.

When to test

• Persistent urethritis or cervicitis that does not improve after standard antibiotics for chlamydia/gonorrhea.
• Pregnant women with preterm labor, unexplained PPROM (pre‑term premature rupture of membranes), or fetal growth restriction.
• Infertility work‑up when other causes have been excluded.
• Recurrent epididymitis or prostatitis.

Treatment Options

Ureaplasma lacks a cell wall, so antibiotics that target cell‑wall synthesis (e.g., penicillins, cephalosporins) are ineffective. The treatment selection follows local resistance patterns and patient factors.

First‑line antibiotics

• Doxycycline 100 mg orally twice daily for 7 days – most commonly prescribed; success rates 80‑90 % (Mayo Clinic, 2023).
• Azithromycin 1 g single dose (or 500 mg daily for 3 days) – convenient, useful in pregnancy (Category B).

Alternative agents

• Fluoroquinolones (e.g., levofloxacin 500 mg daily for 7 days) – reserved for doxycycline‑resistant strains; avoid in pregnancy.
• Clarithromycin 500 mg twice daily for 7 days – an option when macrolide resistance is low.

Treatment of sexual partners

Because reinfection is common, both the patient and their sexual partners should be treated simultaneously, even if the partner is asymptomatic.

Follow‑up testing

Test of cure (TOC) is recommended 3–4 weeks after therapy completion for pregnant women and for those with persistent symptoms. A repeat NAAT is the preferred method.

Lifestyle & supportive measures

• Increase fluid intake to flush the urinary tract.
• Avoid irritants such as scented soaps, douches, and tight‑fitting underwear.
• Practice consistent condom use to reduce reinfection risk.

Living with Ureaplasma Infection

Even after successful treatment, many people wonder how to manage daily life. Below are practical tips.

Managing symptoms

• Pain relief: Over‑the‑counter NSAIDs (ibuprofen 200‑400 mg every 6–8 h) can ease urethral or pelvic discomfort.
• Warm sitz baths: 15‑20 minutes, 2‑3 times daily, may soothe inflammation.
• Hydration: Aim for at least 2 L of water per day to keep urine dilute.

Sexual health

• Abstain from sexual activity until you and your partner have completed treatment and symptoms have resolved.
• Discuss test results openly with partners; transparency reduces repeat infections.
• Consider regular STI screening (every 6–12 months) if you have multiple partners.

Fertility considerations

If you are trying to conceive and have a history of Ureaplasma‑related epididymitis or prostatitis, ask your clinician about a repeat semen analysis after treatment. Many men regain normal sperm parameters within 3 months.

Mental wellbeing

STI diagnoses can be stressful. Seek support from mental‑health professionals, trusted friends, or patient support groups if anxiety or embarrassment interferes with daily life.

Prevention

• Consistent condom use during vaginal, anal, and oral sex reduces transmission risk by ~50 %.
• Limit number of sexual partners and ensure regular testing when you have new partners.
• Pre‑pregnancy screening for pregnant women or couples planning pregnancy can identify and treat colonization early.
• Good genital hygiene – gentle cleaning with water, avoiding harsh chemicals.
• For healthcare workers, adhere strictly to sterile techniques when performing urogenital instrumentation.

Complications

If left untreated, Ureaplasma can lead to serious health problems.

In Women

• Pelvic inflammatory disease (PID) – infection spreads to the uterus, fallopian tubes, or ovaries, increasing risk of infertility.
• Preterm birth & low birth weight – colonization is linked to a 1.5‑fold increase in preterm delivery (WHO, 2021).
• Chronic urinary tract infections – recurrent cystitis may develop.

In Men

• Epididymitis & prostatitis – can become chronic, causing persistent pain.
• Infertility – reduced sperm motility and increased DNA fragmentation have been reported.

In Newborns

• Neonatal pneumonia, conjunctivitis, or sepsis when the infant acquires the organism during birth.

Other systemic effects

• Rare cases of reactive arthritis and rare bloodstream infection in immunocompromised patients.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. “Ureaplasma & Mycoplasma Guidelines.” 2022. cdc.gov/std/tg2015/ureaplasma.htm
• World Health Organization. “Sexually Transmitted Infections (STIs) Fact Sheet.” 2021. who.int
• Mayo Clinic. “Ureaplasma infection – Diagnosis and treatment.” 2023. mayoclinic.org
• Cleveland Clinic. “Ureaplasma Infection: Symptoms, Causes, and Treatment.” 2022. clevelandclinic.org
• National Institutes of Health. “Ureaplasma and Pregnancy Outcomes.” 2022. NCBI

```